Active

GeneriX

Switched

BE0863425803

Rechtspersoon Private limited company 1 establishment

Rue Damry 60, 4100 Seraing Speur- en ontwikkelingswerk op biotechnologisch gebied

Active for

22 year, 6 months

Financials

Financial year 2025

Gross margin

€ 10,530

▲ 144% vs 2024

Profit

Growing

€ 165,675

▲ 384% vs 2024

Debts

Low

€ 39,354

▼ 78% vs 2024

GeneriX from Seraing, company number BE0863425803, closed financial year 2025 with a result of € 165,675 after tax. For that financial year GeneriX recorded a gross margin of € 10,530 and equity of € 961,025. Compared with financial year 2024, the result moved from € -58,252 to € 165,675. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What happened at GeneriX?

What happened at GeneriX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 165,675. filed late Source: NBB ↗
  • Nicolas POELST became a director. NBB
  • Christophe GREFFE became a director. NBB
  • New establishment in Liège. KBO
  • Start of the company according to the CBE. KBO

In short

From € 4,772 profit in 2021 to € 165,675 profit in 2025.

Best year ever: 2025, with € 165,675 profit.

Paid out € 152,160 in dividends to the owners in total.

A new publication or filing at GeneriX? We notify you, reason included.

Follow GeneriX

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Christophe GREFFE
Nicolas POELST
GeneriX

Behind GeneriX are Christophe GREFFE and Nicolas POELST. The same people are also behind GenomiX and X-RIS.

See the full network in the app

Directors

According to the 2025 annual accounts

Christophe GREFFE

Managing director

Also active at: GenomiX

since 2023

Nicolas POELST

Director

Also active at: GenomiX, X-RIS

since 2025

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Damry 60

4100 Seraing

2.135.551.604

Allée de la Cense-Rouge 9

4031 Liège

Active since 13 February 2004

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

Details

Company number
0863.425.803
VAT number
BE 0863.425.803
Registered office
Rue Damry 60, 4100 Seraing
Names & denominations
GeneriX
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
13 February 2004
Peppol
Active · Active since 14 Nov 2025
Activities · NACE

Speur- en ontwikkelingswerk op biotechnologisch gebied

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsvoering en beheer

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Groothandel in andere consumentenartikelen, neg

Overige groothandel in consumentenartikelen, n.e.g.

Frequently asked questions

What is the enterprise number of GeneriX?
The enterprise number of GeneriX is BE0863425803.
What is the address of GeneriX?
The registered office of GeneriX is located at Rue Damry 60, 4100 Seraing.
When was GeneriX founded?
GeneriX was founded on 13 February 2004.
What is the main activity of GeneriX?
The main activity of GeneriX is "Speur- en ontwikkelingswerk op biotechnologisch gebied" (NACE code 72101).
Does GeneriX have a website?
No website is currently known for GeneriX.
How much profit did GeneriX make in 2025?
GeneriX posted a profit after taxes of € 165,675 in financial year 2025.
What is the revenue of GeneriX?
As a small company, GeneriX is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 10,530.
Where can I find the annual accounts of GeneriX?
GeneriX files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of GeneriX?
According to the 2025 annual accounts, the directors of GeneriX are: Christophe GREFFE, Nicolas POELST.
Who owns GeneriX?
Behind GeneriX are Christophe GREFFE and Nicolas POELST. The same people are also behind GenomiX and X-RIS.